Princeton Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-13,420
| Closed | -$1.59M | – | 123 |
|
|
2024
Q2 | $1.59M | Buy |
13,420
+913
| +7% | +$108K | 0.52% | 35 |
|
|
2024
Q1 | $1.33M | Buy |
12,507
+752
| +6% | +$80.1K | 0.48% | 42 |
|
|
2023
Q4 | $1.17M | Sell |
11,755
-2,816
| -19% | -$280K | 0.47% | 45 |
|
|
2023
Q3 | $1.51M | Buy |
14,571
+1,503
| +12% | +$155K | 0.69% | 36 |
|
|
2023
Q2 | $1.59M | Buy |
13,068
+331
| +3% | +$40.2K | 0.66% | 35 |
|
|
2023
Q1 | $1.96M | Sell |
12,737
-271
| -2% | -$41.6K | 0.84% | 32 |
|
|
2022
Q4 | $2.34M | Buy |
13,008
+3
| +0% | +$539 | 1.04% | 30 |
|
|
2022
Q3 | $1.54M | Sell |
13,005
-520
| -4% | -$61.5K | 0.67% | 34 |
|
|
2022
Q2 | $1.93M | Buy |
13,525
+175
| +1% | +$25K | 0.75% | 34 |
|
|
2022
Q1 | $2.3M | Buy |
13,350
+795
| +6% | +$137K | 0.71% | 37 |
|
|
2021
Q4 | $3.19M | Buy |
12,555
+154
| +1% | +$39.1K | 0.91% | 31 |
|
|
2021
Q3 | $4.77M | Buy |
12,401
+131
| +1% | +$50.4K | 1.52% | 20 |
|
|
2021
Q2 | $2.88M | Buy |
+12,270
| New | +$2.88M | 0.89% | 37 |
|